2023-2024 Session
Change SessionH.222 (Act 22)
An act relating to reducing overdoses
- Sponsor(s)
-
- Rep. Dane Whitman
- Additional Sponsors
- Rep. Julia Andrews
- Rep. Sarah "Sarita" Austin
- Rep. Daisy Berbeco
- Rep. Alyssa Black
- Rep. Seth Bongartz
- Rep. Jana Brown
- Rep. Jessica Brumsted
- Rep. Elizabeth Burrows
- Rep. Tesha Buss
- Rep. R. Scott Campbell
- Rep. James Carroll
- Rep. Kevin Christie
- Rep. Esme Cole
- Rep. Leonora Dodge
- Rep. Karen Dolan
- Rep. Anne Donahue
- Rep. Robert "Bobby" Farlice-Rubio
- Rep. Golrang Garofano
- Rep. Leslie Goldman
- Rep. Rodney Graham
- Rep. Troy Headrick
- Rep. Lori Houghton
- Rep. Noah Hyman
- Rep. Kathleen James
- Rep. Emilie Kornheiser
- Rep. Emilie Krasnow
- Rep. Kate Logan
- Rep. Emily Long
- Rep. Eric Maguire
- Rep. Jubilee McGill
- Rep. Kristi Morris
- Rep. Emma Mulvaney-Stanak
- Rep. Logan Nicoll
- Rep. William Notte
- Rep. Daniel Noyes
- Rep. Kelly Pajala
- Rep. Phil Pouech
- Rep. Barbara Rachelson
- Rep. Mike Rice
- Rep. Taylor Small
- Rep. Heather Surprenant
- Rep. Dara Torre
- Rep. Joseph "Chip" Troiano
- Rep. Jonathan Williams
- Rep. Theresa Wood
- Less…
- Last Recorded Action
- Senate 5/12/2023 - House message: Governor approved bill on May 25, 2023
Bill/Resolution Text
- Other Text
-
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to reducing overdoses
Detailed Status
Regular Session 2023-2024
Body | Date | Journal | Calendar | Location | Full Status |
---|
An act relating to reducing overdoses
Roll Call History
Regular Session 2023-2024
Body | Date | Journal | Location | Full Status |
---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to reducing overdoses
Committee Meetings
Regular Session 2023-2024
Meeting Date | Committee |
---|
An act relating to reducing overdoses
Meeting Full List
Regular Session 2023-2024
Wednesday, February 15, 2023
- Committee(s):
- House Committee on Human Services
- 2:30 PM
-
H.222 - An act relating to reducing overdoses
Walk-through
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Wednesday, February 22, 2023
- Committee(s):
- House Committee on Human Services
- 10:15 AM
-
H.222 - An act relating to reducing overdoses
Section 7
Monica Caserta Hutt, Chief Prevention Officer, Office of Governor
Kenneth A Feder, Assistant Scientist, Department of Health, Johns Hopkins Bloomberg School of Public Health
Tim Lueders-Dumont, Legislative & Asst. Appellate Attorney, Vermont Department of State's Attorneys and Sheriffs
- 2:00 PM
-
H.222 - An act relating to reducing overdoses
Section 7
Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform
Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
- 2:25 PM
-
H.222 - An act relating to reducing overdoses
Section 6
Karen Horn, Director, Public Policy & Advocacy, Vermont League of Cities and Towns
Jeff Moreau, Executive Director, Vermont Alliance for Recovery Residences
Christopher Nordle, Nordle & Company, PLLC, Vermont Foundation of Recovery
Wednesday, March 1, 2023
- Committee(s):
- House Committee on Human Services
- 11:00 AM
-
H.222 - An act relating to reducing overdoses
Med-Watch
Fred Lord, CEO, Medical Director, and Chairman of the Board, CT Valley Addiction Recovery, Inc.
Kimberly Blake, University of Vermont Medical Center
- 3:00 PM
-
H.222 - An act relating to reducing overdoses
Syringe Disposal Programs
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Theresa Vezina, Executive Director, Vermont CARES
Thursday, March 2, 2023
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.222 - An act relating to reducing overdoses
Update on Opioid Antagonist Statute & Liability Protection for Syringe Service Providers
David Englander, Senior Policy & Legal Advisor, Department of Health
Gary DeCarolis, Executive Director, Vermont Recovery Network
Samba Diallo, AIDS Project of Southern Vermont
Laura Byrne, Executive Director, HIV/HCV Resource Center
- 10:00 AM
-
H.222 - An act relating to reducing overdoses
Section 6
Gregory Tatro, Co-Founder, Jenna's Promise
Daniel Franklin, Chief Operating Officer, Jenna's Promise
Caroline Butler, Nurse Practitioner, Johnson Health Center
Greg Tatro, Founder/Director, Jenna's Promise
- -
-
H.222 - An act relating to reducing overdoses
Committee discussion
Tuesday, March 14, 2023
- Committee(s):
- House Committee on Human Services
- 9:30 AM
-
H.222 - An act relating to reducing overdoses
Review of Draft 2.4
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- 1:00 PM
-
H.222 - An act relating to reducing overdoses
Sections 8, 9, and 10
Jill Sudhoff-Guerin, Maidstone Public Relations, Vermont Medical Society
Jessa Barnard, Executive Director, Vermont Medical Society
Wednesday, March 15, 2023
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.222 - An act relating to reducing overdoses
Section 1
Karen Horn, Director, Public Policy & Advocacy, Vermont League of Cities and Towns
- 9:20 AM
-
H.222 - An act relating to reducing overdoses
Committee discussion
- 10:30 AM
-
H.222 - An act relating to reducing overdoses
Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform
Justin Morrill, Citizen
Joey Leclair, Citizen
- 11:25 AM
-
H.222 - An act relating to reducing overdoses
Brenda Siegel, Policy Advocate
- 2:30 PM
-
H.222 - An act relating to reducing overdoses
Continued from earlier
Brenda Siegel, Policy Advocate
Thursday, March 16, 2023
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.222 - An act relating to reducing overdoses
Mark-up
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- 10:45 AM
-
H.222 - An act relating to reducing overdoses
Section 8 of draft 2.4
Michael Rapaport, Chief Medical Officer, Department of Vermont Health Access
Andrea DeLaBruere, Commissioner, Department of Vermont Health Access
- 11:45 AM
-
H.222 - An act relating to reducing overdoses
Prior authorization and MAT
Katie Marvin, Vice President, Vermont Medical Society, Lamoille Health Partners
- 2:30 PM
-
H.222 - An act relating to reducing overdoses
Committee discussion
Friday, March 17, 2023
- Committee(s):
- House Committee on Human Services
- 9:00 AM
-
H.222 - An act relating to reducing overdoses
Committee discussion and vote
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Wednesday, March 22, 2023
- Committee(s):
- House Committee on Ways and Means
- 11:15 AM
-
H.222 - An act relating to reducing overdoses
vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Jennifer Carbee, Director and Chief Counsel, Office of Legislative Counsel
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
David Englander, Senior Policy & Legal Advisor, Department of Health
Thursday, March 23, 2023
- Committee(s):
- House Committee on Appropriations
- 10:15 AM
-
H.222 - An act relating to reducing overdoses
Walk-through and vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Wednesday, March 29, 2023
- Committee(s):
- House Committee on Human Services
- 11:00 AM
-
H.222 - An act relating to reducing overdoses
Consideration of Parsons Amendment
Rep. Joseph Parsons, Sponsor of Amendment
Thursday, March 30, 2023
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
H.222 - An act relating to reducing overdoses
Introduction and Walk-through
Rep. Dane Whitman, Reporter, House Committee On Human Services
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Thursday, April 6, 2023
- Committee(s):
- Senate Committee on Health and Welfare
- 10:00 AM
-
H.222 - An act relating to reducing overdoses
Testimony
Katie Marvin, Vice President, Vermont Medical Society, Lamoille Health Partners
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Jessa Barnard, Executive Director, Vermont Medical Society
Theresa Vezina, Executive Director, Vermont CARES
Grey Gardner, Senior Staff Attorney, Drug Policy Alliance
David Englander, Senior Policy & Legal Advisor, Department of Health
Tuesday, April 11, 2023
- Committee(s):
- Senate Committee on Health and Welfare
- 10:00 AM
-
H.222 - An act relating to reducing overdoses
Testimony and Mark Up
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform, Opioid Settlement Advisory Committee Member
Grace Keller, Chair, Vermont Overdose Prevention Network
Thursday, April 13, 2023
- Committee(s):
- Senate Committee on Health and Welfare
- 9:15 AM
-
H.222 - An act relating to reducing overdoses
Discussion and Possible Vote
Jeff Hochberg, President, Vermont Retail Druggists
David Englander, Senior Policy & Legal Advisor, Department of Health
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Friday, April 14, 2023
- Committee(s):
- Senate Committee on Health and Welfare
- 9:30 AM
-
H.222 - An act relating to reducing overdoses
Discussion
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- 10:30 AM
-
H.222 - An act relating to reducing overdoses
Update on Effective Dates
Andrea DeLaBruere, Commissioner, Department of Vermont Health Access
David Englander, Senior Policy & Legal Advisor, Department of Health
- 11:10 AM
-
H.222 - An act relating to reducing overdoses
Vote
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Wednesday, April 19, 2023
- Committee(s):
- Senate Committee on Appropriations
- 1:30 PM
-
H.222 - An act relating to reducing overdoses
Committee Discussion and Possible Vote
Katie McLinn, Legislative Counsel
Tuesday, April 25, 2023
- Committee(s):
- House Committee on Human Services
- 3:20 PM
-
H.222 - An act relating to reducing overdoses
Review of Senate changes
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Thursday, April 27, 2023
- Committee(s):
- House Committee on Judiciary
- 2:45 PM
-
H.222 - An act relating to reducing overdoses
Consideration of Senate Proposal of Amendment
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Friday, April 28, 2023
- Committee(s):
- House Committee on Human Services
- 10:45 AM
-
H.222 - An act relating to reducing overdoses
Committee discussion of proposed further amendment
Michele Childs, Legislative Counsel, Office of Legislative Counsel
- 1:35 PM
-
H.222 - An act relating to reducing overdoses
Discussion of proposed further amendment
David Englander, Senior Policy & Legal Advisor, Department of Health
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- 2:55 PM
-
H.222 - An act relating to reducing overdoses
Vote on proposed further amendment
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Tuesday, May 2, 2023
- Committee(s):
- Senate Committee on Health and Welfare
- 10:30 AM
-
H.222 - An act relating to reducing overdoses
Review of House Changes
Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Tuesday, November 28, 2023
- Committee(s):
- Joint Legislative Justice Oversight Committee
- 1:00 PM
-
H.222 - An act relating to reducing overdoses
Continuity of Treatment for Incarcerated People Reentering Community
Benjamin Novogroski, Legislative Counsel, Office of Legislative Counsel
Andrea De La Bruere, Commissioner, Department of Vermont Health Access
Isaac Dayno, Executive Director of Policy and Strategic Initiatives, Department of Corrections
Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform, Opioid Settlement Advisory Committee Member
Tuesday, December 12, 2023
- Committee(s):
- Joint Legislative Justice Oversight Committee
- 10:00 AM
-
H.222 - An act relating to reducing overdoses
Continuity of Treatment for Incarcerated People Reentering the Community
Nicholas Deml, Commissioner, Department of Corrections
Stephanie Ruckman, VP of Operations-MAT, Wellpath
Kelly Dougherty, Deputy Commissioner, Department of Health
Steve Howard, Executive Director, Vermont State Employees Association
Committee Documents
An act relating to reducing overdoses
Witnesses Who Testified
Regular Session 2023-2024
House Committee on Appropriations
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
House Committee on Human Services
- Jessa Barnard, Executive Director, Vermont Medical Society
- Kimberly Blake, University of Vermont Medical Center
- Caroline Butler, Nurse Practitioner, Johnson Health Center
- Laura Byrne, Executive Director, HIV/HCV Resource Center
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
- Gary DeCarolis, Executive Director, Vermont Recovery Network
- Andrea DeLaBruere, Commissioner, Department of Vermont Health Access
- Samba Diallo, AIDS Project of Southern Vermont
- David Englander, Senior Policy & Legal Advisor, Department of Health
- Kenneth A Feder, Assistant Scientist, Department of Health, Johns Hopkins Bloomberg School of Public Health
- Daniel Franklin, Chief Operating Officer, Jenna's Promise
- Karen Horn, Director, Public Policy & Advocacy, Vermont League of Cities and Towns
- Monica Caserta Hutt, Chief Prevention Officer, Office of Governor
- Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Joey Leclair, Citizen
- Fred Lord, CEO, Medical Director, and Chairman of the Board, CT Valley Addiction Recovery, Inc.
- Tim Lueders-Dumont, Legislative & Asst. Appellate Attorney, Vermont Department of State's Attorneys and Sheriffs
- Katie Marvin, Vice President, Vermont Medical Society, Lamoille Health Partners
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- Jeff Moreau, Executive Director, Vermont Alliance for Recovery Residences
- Justin Morrill, Citizen
- Christopher Nordle, Nordle & Company, PLLC, Vermont Foundation of Recovery
- Rep. Joseph Parsons, Sponsor of Amendment
- Michael Rapaport, Chief Medical Officer, Department of Vermont Health Access
- Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
- Brenda Siegel, Policy Advocate
- Jill Sudhoff-Guerin, Maidstone Public Relations, Vermont Medical Society
- Greg Tatro, Founder/Director, Jenna's Promise
- Gregory Tatro, Co-Founder, Jenna's Promise
- Theresa Vezina, Executive Director, Vermont CARES
House Committee on Judiciary
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
House Committee on Ways and Means
- Jennifer Carbee, Director and Chief Counsel, Office of Legislative Counsel
- David Englander, Senior Policy & Legal Advisor, Department of Health
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
Joint Legislative Justice Oversight Committee
- Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
- Isaac Dayno, Executive Director of Policy and Strategic Initiatives, Department of Corrections
- Andrea De La Bruere, Commissioner, Department of Vermont Health Access
- Nicholas Deml, Commissioner, Department of Corrections
- Kelly Dougherty, Deputy Commissioner, Department of Health
- Steve Howard, Executive Director, Vermont State Employees Association
- Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform, Opioid Settlement Advisory Committee Member
- Benjamin Novogroski, Legislative Counsel, Office of Legislative Counsel
- Stephanie Ruckman, VP of Operations-MAT, Wellpath
Senate Committee on Appropriations
- Katie McLinn, Legislative Counsel
Senate Committee on Health and Welfare
- Jessa Barnard, Executive Director, Vermont Medical Society
- Michele Childs, Legislative Counsel, Office of Legislative Counsel
- Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform
- Andrea DeLaBruere, Commissioner, Department of Vermont Health Access
- David Englander, Senior Policy & Legal Advisor, Department of Health
- Grey Gardner, Senior Staff Attorney, Drug Policy Alliance
- Jeff Hochberg, President, Vermont Retail Druggists
- Grace Keller, Chair, Vermont Overdose Prevention Network
- Jess Kirby, Director of Client Services, Vermonters for Criminal Justice Reform, Opioid Settlement Advisory Committee Member
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Katie Marvin, Vice President, Vermont Medical Society, Lamoille Health Partners
- Katie McLinn, Legislative Counsel, Office of Legislative Counsel
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
- Theresa Vezina, Executive Director, Vermont CARES
- Rep. Dane Whitman, Reporter, House Committee On Human Services
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
Fiscal Information
Fiscal Notes and Related Documents
- H.222 (Act 22) – An act relating to reducing overdoses, As passed by the General Assembly
- H.222 – An act relating to reducing overdoses, As passed by the Senate
- H.222 – An act relating to reducing overdoses, As amended by Senate Committee on Health and Welfare, Draft 6.1, And further amended by the Senate Committee on Appropriations
- H.222 – An act relating to reducing overdoses, As passed by the House
- H.222 – An act relating to reducing overdoses, As recommended by the House Committee on Human Services, Draft 4.1
No committee of conference members found for H.222 in the Regular Session 2023-2024.
An act relating to reducing overdoses
Committee of Conference Meetings
Regular Session 2023-2024
Meeting Date | Committee |
---|
An act relating to reducing overdoses
Committee of Conference Meeting Full List
Regular Session 2023-2024
No committee of conference meeting history found for H.222 in the Regular Session 2023-2024.
No committee of conference report found for H.222 in the Regular Session 2023-2024.
Act
An act relating to reducing overdoses
Statutes Affected
Regular Session 2023-2024
Statute |
---|
8 V.S.A. § 4089i. Prescription drug coverage |
18 V.S.A. § 4201. Definitions |
18 V.S.A. § 4224. Unused Prescription Drug, Needle, and Syringe Disposal Program |
18 V.S.A. § 4234. Depressant, stimulant, and narcotic drugs |
18 V.S.A. § 4240. Prevention and treatment of opioid-related overdoses [Renumbered] |
18 V.S.A. § 4240a. Overdose prevention; drug-checking for contaminant detection [Renumbered] |
18 V.S.A. § 4475. Definitions |
18 V.S.A. § 4750. Definitions |
18 V.S.A. § 4752. Opioid use disorder treatment system |
18 V.S.A. § 4753. Care coordination |
18 V.S.A. § 4774. Opioid Abatement Special Fund |
24 V.S.A. § 4412. Required provisions and prohibited effects |
33 V.S.A. § 1901l. Medication for opioid use disorder |
Staff & Other Information
- Staff
- Katie McLinn, Legislative Counsel
- Notes
- Sec. 14 of S.119 has been incorporated into Act 22 (H.222).